112 related articles for article (PubMed ID: 24342810)
1. Immunosuppressed solid organ transplant recipient.
Stine JG; Shah N; Argo C
Gastroenterology; 2014 Feb; 146(2):345,590. PubMed ID: 24342810
[No Abstract] [Full Text] [Related]
2. Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
Katabathina V; Menias CO; Pickhardt P; Lubner M; Prasad SR
Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation.
Chen KY; Lin CY; Kuo TT; Shih LY; Chang CH; Chen WT; Yang CY
Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.
Scarsbrook AF; Warakaulle DR; Dattani M; Traill Z
Clin Radiol; 2005 Jan; 60(1):47-55. PubMed ID: 15642292
[TBL] [Abstract][Full Text] [Related]
5. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
6. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients.
Touraine JL; Garnier JL; Lefrancois N; Finaz de Villaine J; Dubernard JM; de Thé G; Lenoir G
Transplant Proc; 1989 Feb; 21(1 Pt 3):3197-8. PubMed ID: 2650450
[No Abstract] [Full Text] [Related]
7. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus associated with a post-transplant lymphoproliferative disorder presenting as isolated gastrointestinal tract bleeding.
Badham K; Mirchandani A; Arumainayagam N; West DR
Endoscopy; 2007 Feb; 39 Suppl 1():E64-5. PubMed ID: 17323282
[No Abstract] [Full Text] [Related]
9. Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.
Dyckmans K; Lerut E; Gillard P; Lannoo M; Ectors N; Hoorens A; Mathieu C; Coosemans W; Vanrenterghem Y; Kuypers D
Nephrol Dial Transplant; 2006 Nov; 21(11):3306-10. PubMed ID: 16954176
[No Abstract] [Full Text] [Related]
10. Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient.
Dahiya S; Ooi WB; Ahluwalia MS; Asik A
J Am Geriatr Soc; 2012 Sep; 60(9):1777-8. PubMed ID: 22985151
[No Abstract] [Full Text] [Related]
11. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
12. A case of pediatric PTLD following autologous stem cell transplantation and review of the literature.
Eckrich MJ; Frangoul H; Knight J; Mosse C; Domm J
Pediatr Transplant; 2012 Feb; 16(1):E15-8. PubMed ID: 20819185
[TBL] [Abstract][Full Text] [Related]
13. Fever in a lung transplant recipient.
Walter G; Lyubetska H; Sharma A
Cleve Clin J Med; 2020 Nov; 87(12):735-741. PubMed ID: 33229389
[No Abstract] [Full Text] [Related]
14. A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation.
Hourigan MJ; Doecke J; Mollee PN; Gill DS; Norris D; Johnson DW; Gandhi MK
Br J Haematol; 2008 Jun; 141(6):904-7. PubMed ID: 18422782
[No Abstract] [Full Text] [Related]
15. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant lymphoproliferative disorder of plasmacytoma-like subtype.
Kahl C; Martinez A; Moll S
Br J Haematol; 2007 Nov; 139(4):518. PubMed ID: 17784882
[No Abstract] [Full Text] [Related]
17. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder: a pictorial review.
Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
[TBL] [Abstract][Full Text] [Related]
19. Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD).
Sasaki TM; Pirsch JD; D'Alessandro AM; Knechtle SJ; Kalayoglu M; Hafez GR; Sollinger HW
Clin Transplant; 1997 Feb; 11(1):29-33. PubMed ID: 9067691
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma in organ transplant recipients.
Lancet; 1984 Mar; 1(8377):601-3. PubMed ID: 6142310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
